Diabetogenic effects of streptozotocin in rhesus monkeys.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D001786:Blood Glucose / Q000032:analysis; D004796:Clinical Enzyme Tests; D003920:Diabetes Mellitus / Q000139:chemically induced*; D005215:Fasting; D005260:Female; D005949:Glucose Oxidase; D005951:Glucose Tolerance Test; D000882:Haplorhini; D006943:Hyperglycemia / Q000139:chemically induced*; D007328:Insulin / Q000097:blood; D007515:Islets of Langerhans / Q000187:drug effects / Q000473:pathology; D011863:Radioimmunoassay; D013302:Streptomyces; D013997:Time Factors; D014044:Tolbutamide
D000900:Anti-Bacterial Agents; D001786:Blood Glucose; D007328:Insulin; D014044:Tolbutamide; D005949:Glucose Oxidase